Physician Profile
Mark A. Hulsey, M.D.
Unclaimed ProfileAbout Dr. Hulsey
Mark A. Hulsey, M.D. is a healthcare provider in Edmond, OK specializing in rheumatology. Medicare claims data shows Mark provided 6,563 services to 1,098 patients. The services billed most often include injection, golimumab, 1 mg, for intravenous use, injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered), and established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Specialty
Credentials & Licensing
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Medicare information
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
Contact Information
- (405) 844-4978
- Email not available
Practice Locations
1701 RENAISSANCE BLVD STE 110
Edmond, OK 73013
Conditions Commonly Evaluated or Treated
Within Rheumatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Conditions
Most searched conditions
- Fibromyalgia
- Gout
- Lupus
- Osteoarthritis
- Psoriatic arthritis
- Rheumatoid arthritis
Autoimmune
- Antiphospholipid Syndrome
- Behçet's Disease
- Dermatomyositis
- Dry Eyes and Mouth
- Granulomatosis with Polyangiitis
- IgA Vasculitis
- IgG4-Related Disease
- Inflammatory myopathy
- Lupus Butterfly Rash
- Positive ANA Blood Test
- Relapsing Polychondritis
Bone
- Paget's Disease of Bone
Bone Health
- Osteoporosis
Connective Tissue
- Hypermobility Syndrome
- Mixed Connective Tissue Disease
- Scleroderma skin disease
- Undifferentiated Connective Tissue Disease
Genetic & Connective Tissue
- Joint Hypermobility
Inflammatory
- Adult-Onset Still's Disease
- Polymyalgia rheumatica
- Rib pain
- Sarcoidosis Joint Pain
Joints
- Baker's Cyst
- Chronic Joint Pain
- Enteropathic Arthritis
- Juvenile Idiopathic Arthritis
- Morning Joint Stiffness
- Palindromic Rheumatism
- Pseudogout
- Reactive Arthritis
- Swollen Fingers or Toes
- Swollen Joints
Nerve & Tendon
- Carpal tunnel
Skin & Soft Tissue
- Erythema Nodosum
Skin & Vascular
- Hypothermia And Frostbite At Work
- Mottled Purplish Skin
Soft Tissue
- Lateral hip pain and trochanteric bursitis
- Shoulder Pain
- Tendinitis and tendinopathy
- Trigger finger
Spine & Back
- Ankylosing Spondylitis
- Sacroiliac joint pain
Vascular
- Cold Sensitive Fingers and Toes
- Temporal Arteritis
- Vasculitis
Procedures & services
Most searched procedures
- Arthritis management
- Infusion therapy
- Joint injections
Consultation
- Second Opinion for Autoimmune Disease
Consultations
- Osteoporosis Medication Consultation
Diagnostics & Injections
- Baker's Cyst Aspiration
- Bursa injection
- Carpal tunnel steroid injection
- Joint injection or aspiration
- Knee Joint Injection
- Nailfold Capillaroscopy
- Sacroiliac joint injection
- Salivary Gland Biopsy
- Tendon Sheath Injection
Education & Support
- Biologic self-injection training
Imaging
- Bone Density Scan Referral
- Joint Ultrasound
Injections
- Ankle Joint Injection
- Finger Joint Injections
- Shoulder Cortisone Injection
- Ultrasound-guided hip injection
- Wrist Cortisone Injection
Lab & Diagnostics
- ANCA Blood Test
- Anti-CCP Antibody Test
- HLA-B27 Genetic Test
- Inflammation Blood Tests
- Joint Fluid Analysis
- Lupus Skin Biopsy
- Myositis Antibody Panel
- Rheumatoid Factor Blood Test
Lab Work
- Autoimmune Blood Panel
- Uric Acid Monitoring
Medication Management
- Biologic medication management
- DMARD Medication Management
- Gout Flare Treatment Plan
- Immunosuppressant Drug Monitoring
- Prolia Injection for Osteoporosis
- Reclast Infusion for Osteoporosis
- Steroid Taper Management
Pain Relief
- Trigger Point Injections
Regenerative Medicine
- PRP Therapy for Joints
Procedures Most Often Billed to Medicare
6,563 services · 1,098 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
166 | As often as other peers in Rheumatology |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
46 | Less often than most peers in Rheumatology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
36 | Less often than most peers in Rheumatology |
| Injection of drug or substance under skin or into muscle | Treatment | 96372 |
26 | Less often than most peers in Rheumatology |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Treatment | 96365 |
25 | Less often than most peers in Rheumatology |
| Injection, golimumab, 1 mg, for intravenous use | Drug given | J1602 |
3,200 | Less often than most peers in Rheumatology |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0129 |
1,375 | Less often than most peers in Rheumatology |
| Injection, methylprednisolone sodium succinate, 5 mg | Drug given | J2919 |
100 | Less often than most peers in Rheumatology |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Drug given | J3301 |
68 | Less often than most peers in Rheumatology |
| Injection, methylprednisolone sodium succinate, up to 125 mg | Drug given | J2930 |
18 | Less often than most peers in Rheumatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Related providers
Connections drawn from the registry and from what providers have told us. A link here is not a referral or an endorsement.
Other rheumatologists at this location 3
Same specialty, same street address — most likely the same department or group.
Related specialists at this location 2
Clinically related specialties at the same address — the people this provider most likely works alongside.
Also at this address 4
Providers at the same street address. Each files their own registry entry, so a shared practice often appears under several different names.
More connections — 8 related providers in 1 group
Also performs Insertion of needle into vein for collection of blood sample 8
Providers in OK who bill this service to Medicare most often.
Common questions
What kind of doctor is Mark A. Hulsey?
Mark A. Hulsey is a rheumatologist in Edmond, OK. That is the designation recorded for this NPI in the federal registry, where it is listed as “Rheumatology”.
NPI registry
What is Mark A. Hulsey's address?
Mark A. Hulsey is listed at 1701 Renaissance Blvd Ste 110, Edmond, OK 73013. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
How can I make an appointment with Mark A. Hulsey?
The number on file is (405) 844-4978. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
What is the NPI for Mark A. Hulsey?
Mark A. Hulsey's National Provider Identifier is 1932142361. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
How much experience does Mark A. Hulsey have?
Mark A. Hulsey has 20+ years experience. Registered with an NPI since 2006. National Provider Identifiers only began in 2005, so a provider who qualified earlier may have practiced for longer than this.
NPI registry
What procedures does Mark A. Hulsey perform?
According to Medicare billing data, Mark A. Hulsey performs procedures including insertion of needle into vein for collection of blood sample; provides treatments such as injection of additional new drug or substance into vein and administration of chemotherapy into vein, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Is Mark A. Hulsey's profile verified?
Not yet. This profile is built from public federal data and has not been confirmed by Mark A. Hulsey. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.